Amedisys Stock Investor Sentiment

AMED Stock  USD 90.78  0.18  0.20%   
About 66% of Amedisys' investor base is looking to short. The analysis of overall sentiment of trading Amedisys stock suggests that many investors are alarmed at this time. Amedisys' investor sentiment overview provides quick insight into current market opportunities from investing in Amedisys. The current market sentiment, together with Amedisys' historical and current headlines, can help investors time the market. In addition, many technical investors use Amedisys stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Amedisys stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Amedisys daily returns and investor perception about the current price of Amedisys as well as its diversification or hedging effects on your existing portfolios.
  

Amedisys Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Amedisys can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at news.google.com         
New York State Teachers Retirement System Lowers Stock Position in Amedisys, Inc. - Defense World
Google News at Macroaxis
few days ago at news.google.com         
Short Interest in Amedisys, Inc. Drops By 20.2 percent - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Amedisys, Inc. Given Consensus Rating of Hold by Analysts - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
StockNews.com Initiates Coverage on Amedisys - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Pacer Advisors Inc. Grows Stock Position in Amedisys, Inc. - Defense World
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
Surescripts exploring a sale report
Yahoo News
over two weeks ago at news.google.com         
Amedisys Earns Buy Rating from Analysts at StockNews.com - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
Amedisys, Inc. Position Lifted by Vanguard Group Inc. - Defense World
Google News at Macroaxis
over three weeks ago at news.google.com         
Amedisys Stock Rating Reaffirmed by Raymond James - Defense World
Google News at Macroaxis
over three weeks ago at zacks.com         
Why Amedisys is a Top Value Stock for the Long-Term
zacks News
over three weeks ago at seekingalpha.com         
UnitedHealth deal for Amedisys likely to close despite report of DOJ scutiny - analyst
seekingalpha News
over three weeks ago at finance.yahoo.com         
Why Amedisys is a Top Value Stock for the Long-Term
Yahoo News
over three weeks ago at investing.com         
RBC raises Amedisys stock PT to 100 on AMED deal completion confidence
Investing News at Macroaxis
over three weeks ago at finance.yahoo.com         
Why Is Amedisys Down 2.5 percent Since Last Earnings Report?
Yahoo News
over three weeks ago at finance.yahoo.com         
How Amedisys Stock Stands Out in a Strong Industry
Yahoo News
Far too much social signal, news, headlines, and media speculation about Amedisys that are available to investors today. That information is available publicly through Amedisys media outlets and privately through word of mouth or via Amedisys internal channels. However, regardless of the origin, that massive amount of Amedisys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amedisys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amedisys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amedisys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amedisys alpha.

Amedisys Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Amedisys introduces advanced molecular testing nationwide
02/09/2024
2
Acquisition by Denise Bohnert of 5518 shares of Amedisys subject to Rule 16b-3
02/16/2024
3
Disposition of 1415 shares by Denise Bohnert of Amedisys at 93.69 subject to Rule 16b-3
02/20/2024
4
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
03/07/2024
5
Qube Research Technologies Ltd Purchases Shares of 21233 Amedisys, Inc. - Defense World
03/12/2024
6
Oregons health authority reviewing UnitedHealths acquisition of Amedisys
03/19/2024
7
How Amedisys Stock Stands Out in a Strong Industry
03/20/2024
8
Why Amedisys is a Top Value Stock for the Long-Term
03/25/2024
9
New York State Teachers Retirement System Lowers Stock Position in Amedisys, Inc. - Defense World
04/15/2024
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Amedisys Hype Analysis, Amedisys Correlation and Amedisys Performance.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.30)
Revenue Per Share
68.603
Quarterly Revenue Growth
0.016
Return On Assets
0.0598
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.